ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PRFX vs HCWB // EV/EBITDA & P/E VALUATION

PRF Technologies Ltd. (NASDAQ) VS. HCW Biologics Inc. (NASDAQ) • 15-METRIC TALLY: PRFX 2 — HCWB 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PRFX VS. HCWB) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PRFX HCWB SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin -30.00% 20.00% -50.00 HCWB /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 1/9 +2.00 PRFX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 36.6 31.3 +5.30 PRFX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.6M $2.6M -$13.8K HCWB /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PRFX REV HCWB REV PRFX GROSS % HCWB GROSS % PRFX FCF HCWB FCF
FY 2025 $17.0K $54.2K -50.0% 20.0% -$4.0M -$13.4M
FY 2024 $0 $2.6M — 37.4% -$12.6M -$14.5M
FY 2023 $0 $0 — — -$6.7M -$22.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PRFX // BETA —
HCWB // BETA —